Janice M.G. Canvin,Marla D. Curran,Robert B. Noble,Saku JP Torvinen,James Zangrilli
申请号：
US15689299
公开号：
US20180056018A1
申请日:
2017.08.29
申请国别(地区):
US
年份:
2018
代理人:
摘要：
Digital systems, devices and methods for managing a drug therapy, such as an anti-IL5 mAb or anti-IL5 receptor mAb treatment regimen for patients suffering from severe asthma (e.g., eosinophilic asthma), are provided. The digital systems, devices and methods may include hardware and software for predicting patient responses to a long term anti-IL5 mAb or anti-IL5 receptor mAb treatment based on clinical data obtained following an initial treatment period.
